CN114129142A - Treatment evaluation method - Google Patents
- ️Fri Mar 04 2022
CN114129142A - Treatment evaluation method - Google Patents
Treatment evaluation method Download PDFInfo
-
Publication number
- CN114129142A CN114129142A CN202111256433.XA CN202111256433A CN114129142A CN 114129142 A CN114129142 A CN 114129142A CN 202111256433 A CN202111256433 A CN 202111256433A CN 114129142 A CN114129142 A CN 114129142A Authority
- CN
- China Prior art keywords
- patient
- blood pressure
- treatment
- test
- self Prior art date
- 2021-10-27 Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000011156 evaluation Methods 0.000 title claims abstract description 14
- 230000036772 blood pressure Effects 0.000 claims abstract description 43
- 238000012360 testing method Methods 0.000 claims abstract description 33
- 239000003814 drug Substances 0.000 claims abstract description 19
- 238000005259 measurement Methods 0.000 claims abstract description 18
- 206010020772 Hypertension Diseases 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 15
- 230000000694 effects Effects 0.000 claims abstract description 5
- 229940079593 drug Drugs 0.000 claims description 10
- 238000007405 data analysis Methods 0.000 claims description 3
- 210000002784 stomach Anatomy 0.000 claims description 3
- 238000002560 therapeutic procedure Methods 0.000 claims description 3
- 239000000779 smoke Substances 0.000 claims 1
- 230000002349 favourable effect Effects 0.000 abstract description 3
- 208000024172 Cardiovascular disease Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 2
- 238000009530 blood pressure measurement Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000035487 diastolic blood pressure Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000035488 systolic blood pressure Effects 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000035485 pulse pressure Effects 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
- A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Cardiology (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Abstract
The invention discloses a treatment evaluation method, which relates to the technical field of medical evaluation and comprises the following steps: s1, obtaining blood pressure values of multiple volunteers with determined absence of hypertension as horizontal reference value A by sphygmomanometer measurement0(ii) a S2, performing blood pressure self-test at frequency of three times per day in one week after discharge of hypertension patient, and recording time of good test and test value An(ii) a S3, arranging all the data measured in S2 according to the steps from small to large, and then calculating the median X of the datan(ii) a S4, calculating the median X in S3nWith a horizontal reference value A0And comparing, judging the actual treatment effect of the patient, and issuing a corresponding treatment scheme and a medicine adjustment scheme. The method can reduce the influence of additional factors on the treatment evaluation of the patient, simultaneously can abandon the extreme measurement value of the patient within a period of time, and is favorable for better reflecting the actual condition of the patientThe method is described.
Description
Technical Field
The invention relates to the technical field of medical evaluation, in particular to a treatment evaluation method.
Background
Hypertension is a clinical syndrome characterized by an increase in systemic arterial blood pressure (systolic pressure and/or diastolic pressure) and may be accompanied by functional or organic impairment of organs such as heart, brain, and kidney. Hypertension is the most common chronic disease and also the most major risk factor for cardiovascular and cerebrovascular diseases. The blood pressure of a normal person fluctuates within a certain range along with the changes of internal and external environments. In the whole population, the blood pressure level gradually increases with age, the systolic pressure is more obvious, but the diastolic pressure shows a descending trend after the age of 50, and the pulse pressure is increased. In recent years, people have increasingly deep knowledge on the effects of multiple risk factors of cardiovascular diseases and the protection of target organs of heart, brain and kidney, the diagnosis standard of hypertension is continuously adjusted, and at present, patients with the same blood pressure level are considered to have different cardiovascular disease risks, so that the concept of blood pressure stratification is provided, namely, the patients with different cardiovascular disease risks are different in proper blood pressure level.
The main hypertension group is the middle-aged and old people group, is the genuine invisible killer, with people's deepening to the degree of attention of healthy, and medical development, hypertension crowd can control blood pressure in a stable scope through the medicine now, the standard of judging to hypertension of hospital all is through the standard that Chinese hypertension treatment guideline in 2005 now, because the difference of personnel's physique and habits and customs in different areas, probably lead to actual aassessment to the deviation, and single testing result also does not have the representativeness, can not be fine reaction patient's actual blood pressure condition.
Disclosure of Invention
The invention aims to solve the problems that in the prior art, deviation can occur in actual evaluation due to differences of constitutions and living habits of people in different regions, single detection results are not representative, and actual blood pressure conditions of patients cannot be reflected well.
In order to achieve the purpose, the invention adopts the following technical scheme:
a method of therapy assessment comprising the steps of:
s1, obtaining blood pressure values of multiple volunteers with determined absence of hypertension as horizontal reference value A by sphygmomanometer measurement0;
S2, performing blood pressure self-test at frequency of three times per day in one week after discharge of hypertension patient, and recording time of good test and test value An;
S3, arranging all the data measured in S2 according to the steps from small to large, and then calculating the median X of the datan;
S4, calculating the median X in S3nWith a horizontal reference value A0And comparing, judging the actual treatment effect of the patient, and issuing a corresponding treatment scheme and a medicine adjustment scheme.
Preferably, the plurality of volunteers should be in a plurality of age groups and need to have volunteers with different sexes, and the volunteers with different sexes are divided into two groups according to male and female, and measured in a small group at intervals of five years, thereby obtaining the horizontal reference value A0。
Preferably, the patient's frequency of self-tests per day may be three times per day or once every five hours.
Preferably, the patient's self-test time is preferably measured first in the morning on an empty stomach, second two hours after lunch and third one hour before bedtime.
Preferably, care should be taken to maintain a seated position during the patient's self-test, and no vigorous movement should be taken within the first two hours of the test.
Preferably, the patient self-tests using an electronic sphygmomanometer, and also requests the doctor to perform blood pressure measurement through the hospital.
Preferably, in the measurement result obtained by the self-test, a group of measurement values A are obtained after being arranged from large to small1A2A3……AnAccording to the formula Xn=A(n+1)/2The median was obtained.
Preferably, according to the median number XnWith a horizontal reference value A0When the comparison of (2) is carried out for result evaluation;
when X is presentn>A0+5, indicating that the blood pressure of the patient is higher than normal after treatment and requiring drugs to assist the patient in blood pressure control;
when A is0-5<Xn<A0+5, indicating that the blood pressure of the patient is at a normal level after treatment, the medication can be properly reduced or the medication can be stopped temporarily;
when X is presentn<A0And 5, indicating that the blood pressure of the patient is lower than a normal level after treatment, and stopping taking medicine immediately and paying close attention to the change of the blood pressure.
Preferably, when patient self-test data is aligned with horizontal reference data, the patient should be aligned with volunteer data of the same sex and age group.
Preferably, at the time of data analysis, the patient should be asked for past medical history and focused on whether the patient smokes, whether the abdomen is obese, and the like.
Compared with the prior art, the invention has the following advantages:
according to the invention, by collecting the median of the change condition of the blood pressure of the patient in one week and comparing the change condition with the blood pressure state of volunteers with the same age range and the same sex in the area, the influence of additional factors on the treatment evaluation of the patient is reduced, extreme measurement values of the patient within a period of time can be abandoned, the actual condition of the patient can be better reflected, a doctor can accurately evaluate the patient conveniently, and the problems that the actual evaluation is deviated due to the difference of the physique and the living habit of personnel in different areas in the prior art, and the single detection result is not representative and cannot well reflect the actual blood pressure condition of the patient are solved.
Detailed Description
A method of therapy assessment comprising the steps of:
s1, obtaining blood pressure values of multiple volunteers with determined absence of hypertension as horizontal reference value A by sphygmomanometer measurement0By searching volunteers in the same region, the variable factors possibly existing between the volunteers and the patient can be reduced as much as possible,to improve the accuracy of treatment assessment.
The volunteers are required to be in multiple age groups and have different sexes, the volunteers with different sexes are divided into two groups according to male and female, when different patients are compared, the gender is firstly distinguished, data deviation caused by gender factors is avoided, the volunteers are divided into one group at intervals of five years for measurement, in order to reduce the data volume deviation caused by age, the age sections of the thinned volunteers are distinguished as much as possible, and therefore the horizontal reference value A is obtained0。
S2, in the period of one week after the discharge of the hypertensive, the blood pressure may be reduced for a short time due to the treatment and drug control of the patient in the hospital, but the discharge may cause the blood pressure to rise again due to the lack of scientific health guidance before the patient resumes work, and the aunt may arouse the attention of the patient and the doctor, need to perform self-test after the discharge for subsequent evaluation, perform the self-test of the blood pressure at a frequency of three times a day, and record the time of the test and the test value An;
The patient can measure the blood pressure value of the patient at different time periods every day, wherein the patient can measure the blood pressure value three times every day or once every five hours, so as to know the actual blood pressure condition of the patient more accurately.
The self-testing time of the patient is preferably the first time of measurement in the morning on an empty stomach, the second time of measurement two hours after lunch and the third time of measurement one hour before sleeping, which is favorable for accurately measuring the blood pressure and avoids the influence of diet on the blood pressure.
Wherein, in the process of patient's self-test, should pay attention to keep the position of sitting, the position of sitting is favorable to the vehicle of blood pressure more, and should not violently move in measuring the first two hours, avoids the blood pressure rise that the motion leads to, easily causes the inaccuracy of data.
When a patient performs self-measurement, the electronic sphygmomanometer can be used for self-measurement, and a doctor can be requested to perform blood pressure measurement through a hospital.
S3, arranging all the data measured in S2 according to the steps from small to large, and then calculating the median X of the datanThe median can more accurately reflect the median of a group of data, reduce the influence of extreme values on the whole group of data, and avoid the influence of some inaccurate data on the whole group of measured data by self-test of patients.
Wherein, in the measurement result obtained by self-test, a group of measurement values A are obtained after being arranged from large to small1A2A3……AnAccording to the formula Xn=A(n+1)/2Obtaining median, if the number of the measured data is even number, selecting two middle numbers, and taking the average number to obtain Xn。
S4, calculating the median X in S3nWith a horizontal reference value A0And comparing, judging the actual treatment effect of the patient, and issuing a corresponding treatment scheme and a medicine adjustment scheme.
Wherein, according to the median XnWith a horizontal reference value A0When the comparison of (2) is carried out for result evaluation;
when X is presentn>A0+5, indicating that the blood pressure of the patient is higher than normal after treatment and requiring drugs to assist the patient in blood pressure control;
when A is0-5<Xn<A0+5, indicating that the blood pressure of the patient is at a normal level after treatment, the medication can be properly reduced or the medication can be stopped temporarily;
when X is presentn<A05, indicating that the blood pressure of the patient is lower than the normal level after treatment, stopping the medicine immediately and paying close attention to the change of the blood pressure, and knowing the actual condition of the patient through comparison and clearance so as to conveniently and accurately evaluate the state of the patient and perform proper medicine adjustment on the patient.
Wherein, when the patient self-test data is compared with the horizontal reference data, the patient should be compared with the data of volunteers in the same sex and age group.
In the data analysis, the past medical history of the patient should be inquired, and the factors of whether the patient smokes, whether the abdomen is fat, and the like should be paid attention to.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.
Claims (10)
1. A method of therapy assessment comprising the steps of:
s1, obtaining blood pressure values of multiple volunteers with determined absence of hypertension as horizontal reference value A by sphygmomanometer measurement0;
S2, performing blood pressure self-test at frequency of three times per day in one week after discharge of hypertension patient, and recording time of good test and test value An;
S3, arranging all the data measured in S2 according to the steps from small to large, and then calculating the median X of the datan;
S4, calculating the median X in S3nWith a horizontal reference value A0And comparing, judging the actual treatment effect of the patient, and issuing a corresponding treatment scheme and a medicine adjustment scheme.
2. The method of claim 1, wherein the volunteers are of different ages and need to have volunteers with different sexes, and the volunteers with different sexes are divided into two groups according to male and female, and measured in a group separated by five years to obtain the level reference A0。
3. A method of treatment assessment according to claim 1, wherein the patient's self-test frequency may be measured three times a day or once every five hours.
4. A treatment assessment method according to claim 3, wherein the patient's self-test time is preferably measured first in the morning on an empty stomach, second two hours after lunch and third one hour before sleep.
5. A treatment assessment method according to claim 1, wherein during the patient's self-test, care should be taken to maintain a sitting position and no vigorous movements should be made within the two hours prior to the test.
6. A treatment assessment method according to claim 1, wherein the patient self-tests either with an electronic sphygmomanometer or by requesting a doctor from the hospital.
7. A treatment assessment method according to claim 1, characterized in that in the self-test measurements, after being arranged in descending order, a set of measurements a is obtained1A2A3……AnAccording to the formula Xn=A(n+1)/2The median was obtained.
8. A method of treatment assessment according to claim 1, wherein the median X is used as the basisnWith a horizontal reference value A0When the comparison of (2) is carried out for result evaluation;
when X is presentn>A0+5, indicating that the blood pressure of the patient is higher than normal after treatment and requiring drugs to assist the patient in blood pressure control;
when A is0-5<Xn<A0+5, indicating that the blood pressure of the patient is at a normal level after treatment, the medication can be properly reduced or the medication can be stopped temporarily;
when X is presentn<A0And 5, indicating that the blood pressure of the patient is lower than a normal level after treatment, and stopping taking medicine immediately and paying close attention to the change of the blood pressure.
9. A method of treatment assessment according to claim 1, wherein when patient self-test data is compared to horizontal reference data, the patient is compared to volunteer data of the same sex and age group.
10. A treatment assessment method according to claim 1, wherein the patient should be asked for past medical history at the time of data analysis, and the patient should be concerned about whether they smoke, whether they are obese or not.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111256433.XA CN114129142A (en) | 2021-10-27 | 2021-10-27 | Treatment evaluation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111256433.XA CN114129142A (en) | 2021-10-27 | 2021-10-27 | Treatment evaluation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114129142A true CN114129142A (en) | 2022-03-04 |
Family
ID=80394673
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111256433.XA Pending CN114129142A (en) | 2021-10-27 | 2021-10-27 | Treatment evaluation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114129142A (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002095641A (en) * | 2000-09-26 | 2002-04-02 | Japan Science & Technology Corp | Method of supporting clinical treatment and clinical trial and recording medium to record supporting program |
US20120143070A1 (en) * | 2009-06-30 | 2012-06-07 | Yiming Yao | Blood pressure detection method and an apparatus therefor |
CN102715896A (en) * | 2012-06-28 | 2012-10-10 | 鹿得医疗器械(南通)有限公司 | Electronic sphygmomanometer with blood pressure data analysis and management functions |
CN105447334A (en) * | 2016-01-08 | 2016-03-30 | 重庆大学 | Hypertension diagnosing, treating and managing system based on Android platform |
CN106845113A (en) * | 2017-01-22 | 2017-06-13 | 贵阳康康慢病互联网医院有限公司 | A kind of chronic disease method for remote management and its management system based on monitoring of blood pressure |
-
2021
- 2021-10-27 CN CN202111256433.XA patent/CN114129142A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002095641A (en) * | 2000-09-26 | 2002-04-02 | Japan Science & Technology Corp | Method of supporting clinical treatment and clinical trial and recording medium to record supporting program |
US20120143070A1 (en) * | 2009-06-30 | 2012-06-07 | Yiming Yao | Blood pressure detection method and an apparatus therefor |
CN102715896A (en) * | 2012-06-28 | 2012-10-10 | 鹿得医疗器械(南通)有限公司 | Electronic sphygmomanometer with blood pressure data analysis and management functions |
CN105447334A (en) * | 2016-01-08 | 2016-03-30 | 重庆大学 | Hypertension diagnosing, treating and managing system based on Android platform |
CN106845113A (en) * | 2017-01-22 | 2017-06-13 | 贵阳康康慢病互联网医院有限公司 | A kind of chronic disease method for remote management and its management system based on monitoring of blood pressure |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9026202B2 (en) | 2015-05-05 | Cardiac performance monitoring system for use with mobile communications devices |
US20080294021A1 (en) | 2008-11-27 | System and Method for the Management or Control of Cardiovascular Related Diseases, Such as Hypertension |
US20040148140A1 (en) | 2004-07-29 | Patient condition display |
US20040133079A1 (en) | 2004-07-08 | System and method for predicting patient health within a patient management system |
KR101674997B1 (en) | 2016-11-10 | Wearable Apparatus, Server, System, and Method for Extracting Parameters of Cardiovascular |
US9402597B1 (en) | 2016-08-02 | Mobile vascular health evaluation processes |
WO2019166613A1 (en) | 2019-09-06 | Methods and systems for measuring a stress indicator, and for determining a level of stress in an individual |
CN110786865A (en) | 2020-02-14 | System and method for controlling blood glucose using personalized histograms |
Head et al. | 2011 | Ambulatory blood pressure monitoring |
Ring et al. | 1994 | Cardiac stimulus intensity and heartbeat detection: Effects of tilt‐induced changes in stroke volume |
Hofmann et al. | 2023 | A novel smartphone app for blood pressure measurement: a proof-of-concept study against an arterial catheter |
Gibbons et al. | 2004 | The evaluation of small fiber function—autonomic and quantitative sensory testing |
CN114129142A (en) | 2022-03-04 | Treatment evaluation method |
Johnson | 1997 | Using cluster analysis to develop a healing typology in vascular ulcers |
KR20190117205A (en) | 2019-10-16 | Method and apparatus for measuring pain depth using photoplethysmograph |
Kasap Demir et al. | 2023 | Blood pressure parameters affecting ventricular repolarization in obese children |
Schell et al. | 2010 | Forearm and upper-arm oscillometric blood pressure comparison in acutely III adults |
Abdelkarim et al. | 2020 | Effect of Body Position Change on Blood Pressure Readings from Both Arms |
RU2543293C2 (en) | 2015-02-27 | Individual's physiological parameters control device |
Yamasue et al. | 2023 | PS-C07-5: ASSOCIATION OF OVERNIGHT URINARY INDICATORS AND BMI WITH NIGHT TIME AND DAYTIME BLOOD PRESSURE IN ELDERLY |
RU2694262C1 (en) | 2019-07-11 | Method of treating compensated and decompensated disturbed cardiac hemodynamic in acute verapamil poisoning |
Sovic et al. | 2023 | CLINICAL INERTIA AND ADHERENCE IN THE CROATIAN RURAL AREA DAMAGED BY AN EARTHQUAKE.“THE SILENT KILLER HUNT”-CROATIAN SOCIETY OF HYPERTENSION PROJECT |
Karim et al. | 2023 | THERAPEUTIC COMPLIANCE IN HYPERTENSIVE PATIENTS: A CROSS SECTIONAL STUDY |
Porfir’Eva | 2024 | Development to New Methodology for Determining Calibration Factors in Escco Technology |
Logvinenko et al. | 2017 | [PP. 16.21] HEART RATE VARIABILITY IN PATIENTS WITH RESISTANTS WITH ARTERIAL HYPERTENSION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
2022-03-04 | PB01 | Publication | |
2022-03-04 | PB01 | Publication | |
2022-03-22 | SE01 | Entry into force of request for substantive examination | |
2022-03-22 | SE01 | Entry into force of request for substantive examination | |
2024-09-10 | RJ01 | Rejection of invention patent application after publication | |
2024-09-10 | RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220304 |